Moreover, liver steatosis and elevated us-CRP in addition to dyslipidemia and overweight indicated that not only a NAFL, but possibly a NASH cohort had been recruited. The gene discussed is CRP; the disease is metabolic dysfunction-associated steatohepatitis.